Benzenesulfonamide analogs of fluoroquinolones. Antibacterial activity and QSAR studies

被引:89
作者
Nieto, MJ [1 ]
Alovero, FL [1 ]
Manzo, RH [1 ]
Mazzieri, MR [1 ]
机构
[1] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Farmacia, RA-5000 Cordoba, Argentina
关键词
antimicrobial; fluoroquinolones; ciprofloxacin; QSAR; SAR; lipophilicity;
D O I
10.1016/j.ejmech.2004.11.008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The structure-activity relationships (SAR) of new antibacterial benzenesulfonamidefluoroquinolones (BSFQs), coming from derivatization of N-4-piperazinyl of ciprofloxacin (CIP) were studied. The behavior of the new BSFQ series was similar to the previously norfloxacin (NOR) analogs reported, making possible a quantitative structure-activity relationships (QSAR) analysis of the complete set of BSFQs. The presence of the benzenesulfonylamido (BS) groups shifted the activity of classic antimicrobial fluoroquinolones from being more active against Gram-negative to Gram-positive strains. QSAR studies through Hansch analysis showed a linear correlation of the activity with electronic and steric parameters. Small electron-donor groups would increase the in vitro activity against Gram-positive bacteria. Hydrophobic properties played a minor role when activity is measured as minimum inhibitory concentration (MIC). QSAR analysis also reinforces previous biological findings about the presence of new interactions with target topoisomerases. (c) 2005 Elsevier SAS. All rights reserved.
引用
收藏
页码:361 / 369
页数:9
相关论文
共 42 条
  • [21] Hansch C., 1995, Exploring QSAR-Fundamentals and Applications in Chemistry and Biology
  • [22] Hooper D.C., 2003, Quinolone Antimicrobial Agents
  • [23] HOOPER DC, 2001, CLIN INFECT DIS S1, V32, P9
  • [24] Kubinyi H., 1993, METHODS PRINCIPLES M
  • [25] Leo A, 1995, EXPLORING QSAR FUNDA
  • [26] Using SAR and QSAR analysis to model the activity and structure of the quinolone-DNA complex
    Llorente, B
    Leclerc, F
    Cedergren, R
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (01) : 61 - 71
  • [27] LORIAN V, 1995, QUANT STRUCT-ACT REL, V14, P134
  • [28] MANZO R, 1997, Patent No. P970106669
  • [29] Manzo R.H., 1995, Antibacterial 7-[4-[(4-aminophenyl)sulfonyl]-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid derivatives and synthesis thereof, Patent No. [5395936, US5395936]
  • [30] Martin YC, 1978, QUANTITATIVE DRUG DE